Lauren M. Sabella - Sep 3, 2021 Form 4 Insider Report for ACORDA THERAPEUTICS INC (ACOR)

Role
Chief Commercial Officer
Signature
/s/ Lauren Sabella
Stock symbol
ACOR
Transactions as of
Sep 3, 2021
Transactions value $
-$6,618
Form type
4
Date filed
9/8/2021, 07:21 AM
Next filing
Sep 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACOR Common Stock Tax liability -$6.62K -1.51K -11% $4.38 12.2K Sep 3, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the number of shares of the issuer's Common Stock that were withheld to cover tax liability in connection with vesting and settlement of restricted stock units reported on a prior Form 4.